Summary
Definition
History and exam
Key diagnostic factors
- age <4 years
- abdominal distension
- abdominal mass
- pain
- decreased appetite
- weight loss
- fussiness (infants)
- fatigue
- periorbital ecchymosis (raccoon eyes)
- subcutaneous skin nodules
- family history of neuroblastic tumors
- signs of spinal cord compression
- signs of Horner syndrome
- signs of superior vena cava syndrome
- intractable secretory diarrhea
- opsoclonus-myoclonus ataxia (OMA)
Other diagnostic factors
- constipation
- pallor
- bleeding
- infections
- hypertension
- hepatomegaly
Risk factors
- neurocristopathies or other syndromes
- family history of neuroblastic tumors or genetic predisposition
Diagnostic tests
1st tests to order
- CBC
- serum electrolytes
- serum creatinine/BUN
- liver function tests (LFTs)
- serum lactate dehydrogenase (LDH)
- urine catecholamines
- ultrasound abdomen
- CT scan
- MRI scan
Tests to consider
- tumor biopsy
- bilateral bone marrow aspiration and biopsy
- serum vasoactive intestinal peptide (VIP)
- 123-iodine-metaiodobenzylguanidine (MIBG) scintigraphy
- positron emission tomography with 18-F-deoxyglucose (18F-FDG PET)
Treatment algorithm
low-risk disease
intermediate-risk disease
high-risk disease
relapsed or refractory disease
Contributors
Authors
Jason Shohet, MD, PhD
Associate Professor
University of Massachusetts
Chan Medical School
Worcester
MA
Disclosures
JS declares that he has no competing interests.
Jennifer Foster, MD, MPH
Clinical Director, Neuroblastoma Program
Associate Professor
Department of Pediatrics Section of Hematology/Oncology
Texas Children's Cancer Center
Baylor College of Medicine
Houston
TX
Disclosures
JF has served on the advisory board for Y-mAbs Therapeutics and Fennec Pharmaceuticals.
Peer reviewers
Juliet C Gray, MB, BS, MA, MRCPCH, PhD
Associate Professor and Consultant in Paediatric Oncology
University of Southampton
Southampton
UK
Disclosures
JCG declares that she has no competing interests.
Daniel Weiser, MD
Medical Director, Intra-Abdominal Solid Tumor Program
Children's Hospital at Montefiore
Assistant Professor, Departments of Pediatrics & Genetics
Albert Einstein College of Medicine
Bronx
NY
Disclosures
DW declares that he has no competing interests.
David Ziegler, MBBS, BSc (Med), FRACP, MD/PhD
Senior Staff Specialist
Sydney Children’s Hospital
Randwick
Sydney
Australia
Disclosures
DZ declares that he has no competing interests.
References
Key articles
Brisse HJ, McCarville MB, Granata C, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology. 2011 Oct;261(1):243-57.Full text Abstract
National Comprehensive Cancer Network. Neuroblastoma [internet publication].Full text
Park JR, Bagatell R, Cohn SL, et al. Revisions to the International Neuroblastoma Response Criteria: a consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017 Aug 1;35(22):2580-7.Full text Abstract
Irwin MS, Naranjo A, Zhang FF, et al. Revised neuroblastoma risk classification system: a report from the Children's Oncology Group. J Clin Oncol. 2021 Oct 10;39(29):3229-41. Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Wilms tumor
- Ewing sarcoma
- Rhabdomyosarcoma
More DifferentialsGuidelines
- NCCN clinical practice guidelines in oncology: neuroblastoma
- Revisions to the International Neuroblastoma Response Criteria
More GuidelinesLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer